XML 37 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Goodwill and Other Intangible Assets Goodwill (Tables)
6 Months Ended
Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Description of unobservable inputs used in Level 3 fair value measurements [Table Text Block]
The recurring Level 3 fair value measurements of our contingent consideration liabilities include the following significant unobservable inputs:
Contingent Consideration Liabilities
Fair Value as of June 30, 2017
Valuation Technique
Unobservable Input
Range
R&D and Commercialization-based Milestones
$44 million
Discounted Cash Flow
Discount Rate
2% - 3%
Projected Year of Payment
2017 - 2021
Revenue-based Payments
$58 million
Discounted Cash Flow
Discount Rate
11% - 15%
Projected Year of Payment
2017 - 2026
Schedule of Goodwill [Table Text Block]
The following represents our goodwill balance by global reportable segment:
(in millions)
Cardiovascular
 
Rhythm Management
 
MedSurg
 
Total
Balance as of December 31, 2016
$
3,513

 
$
290

 
$
2,875

 
$
6,678

Impact of foreign currency fluctuations and other changes in carrying amount

4

 
1

 
3

 
8

Goodwill acquired
185

 

 

 
185

Balance as of June 30, 2017
$
3,702

 
$
291

 
$
2,878

 
$
6,871

The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill as of June 30, 2017 and December 31, 2016 are as follows:
 
As of
 
June 30, 2017
 
December 31, 2016
 
Gross Carrying
 
Accumulated
Amortization/
 
Gross
Carrying
 
Accumulated
Amortization/
(in millions)
Amount
 
Write-offs
 
Amount
 
Write-offs
Amortizable intangible assets
 
 
 
 
 
 
 
Technology-related
$
9,390

 
$
(4,675
)
 
$
9,123

 
$
(4,468
)
Patents
511

 
(370
)
 
529

 
(374
)
Other intangible assets
1,632

 
(779
)
 
1,583

 
(722
)
 
$
11,533

 
$
(5,824
)
 
$
11,235

 
$
(5,564
)
Unamortizable intangible assets
 
 
 
 
 
 
 
Goodwill
$
16,771

 
$
(9,900
)
 
$
16,578

 
$
(9,900
)
In-process research and development (IPR&D)
92

 

 
92

 

Technology-related
120

 

 
120

 

 
$
16,983

 
$
(9,900
)
 
$
16,790

 
$
(9,900
)
The following is a rollforward of accumulated goodwill write-offs by global reportable segment:
(in millions)
Cardiovascular
 
Rhythm Management
 
MedSurg
 
Total
Accumulated write-offs as of December 31, 2016
$
(1,479
)
 
$
(6,960
)
 
$
(1,461
)
 
$
(9,900
)
Goodwill written off

 

 

 

Accumulated write-offs as of June 30, 2017
$
(1,479
)
 
$
(6,960
)
 
$
(1,461
)
 
$
(9,900
)